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Abstract—Opioids are the preferred medications for the
treatment of pain in the intensive care unit. While under-
treatment leads to unrelieved pain and poor clinical outcomes,
excessive use of opioids puts patients at risk of experiencing
multiple adverse effects. In this work, we present a sequen-
tial decision making framework for opioid dosing based on
deep reinforcement learning. It provides real-time clinically
interpretable dosing recommendations, personalized according
to each patient’s evolving pain and physiological condition.
We focus on morphine, one of the most commonly prescribed
opioids. To train and evaluate the model, we used retrospective
data from the publicly available MIMIC-3 database. Our results
demonstrate that reinforcement learning may be used to aid
decision making in the intensive care setting by providing
personalized pain management interventions.
I. INTRODUCTION
Critically ill patients in the intensive care unit (ICU)
commonly experience pain because of a multitude of factors
including surgery, trauma, burns, and cancer, as well as
enduring procedural pain [1]. Regardless of source, poorly
managed pain adversely affects multiple organ systems and
has a direct impact on outcomes, as the negative physiologic
and psychologic consequences of pain are significant, long
lasting, and can preclude patients from participating in their
care.
In the ICU, opioids are the primary systemic medications
for managing pain. The optimal choice of opioid and the dos-
ing regimen used for an individual patient depend on many
factors, including the intensity of pain. To assess the latter as
well as to measure response to treatment, multiple pain inten-
sity scales have been developed. These are unidimensional
scales that measure intensity from 0 (no pain) to 10 (worst
possible pain). Unfortunately, pain assessment scales fail in
multiple patient populations (e.g. non-verbal children) and
clinical situations (e.g. during paralysis). Hence, in recent
years, an increasing body of work is addressing the problem
of pain measurement using machine leaning with autonomic
[2], brain activity [3] and facial expression [4] data, and by
stratifying patients based on their pain responses to allow
for personalized assessments [5]. However, machine learning
for automatic pain management interventions remains an
unexplored area.
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In this work, we propose a novel approach for the au-
tomatic dosing of analgesics based on deep reinforcement
learning. Specifically, we focus on morphine, one of the most
commonly prescribed opioids in the ICU and a first line
for the treatment of pain. Both under-treatment and over-
treatment with morphine lead to severe adverse effects, such
as those related to unrelieved pain and respiratory depression
respectively. Our model aims to learn clinically interpretable
optimal treatment policies and recommend individualized
morphine interventions adapted to each patient’s evolving
state, to minimize pain while avoiding adverse effects. To our
knowledge, our work is the first to apply reinforcement learn-
ing for the recommendation of pain management regimes and
the automatic dosing of analgesics.
II. BACKGROUND AND RELATED WORK
Reinforcement learning (RL) algorithms model time-
varying state and action spaces, and learn actionable policies
pi (mappings from states to actions) from training examples
that do not represent optimal behaviour. At each time step
t, the RL agent observes the current environment state st
and takes an action at ∈ A from a discrete set of actions
A , subsequently receiving a reward rt and transitioning to
a new state st+1. The action at is chosen following policy
pi so that the return or expected sum of future rewards Rt =
rt +γrt+1+γ2tt+2+ ... when taking that action and following
policy pi thereafter is maximized. The future rewards are
discounted by a factor γ that represents the trade off between
immediate and later rewards.
Combining RL with deep neural networks has achieved
tremendous success in complex problems such as the Atari,
Go, and chess games [6], [7]. In medicine, deep reinforce-
ment learning has been applied, for example, to unfractioned
heparin dosing in the ICU [8], intravenous fluid and vaso-
pressor dosing in sepsis patients [9], [10], and chemotherapy
dosing in cancer patients enrolled in clinical trials [11].
III. METHODS
Morphine analgesia is characterized by tremendous in-
terindividual variation and is influenced by multiple factors
[12]. Hence, in the ICU, physicians continuously monitor
patients to personalize morphine pain management. Our goal
is to deduce optimal treatment policies, similar to those of
physicians, that account for pain level as well as physio-
logical state as captured by vital signs. We chose RL over
supervised learning because no ground truth for treatment
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strategies exists and RL is able to infer optimal strategies
from suboptimal training examples.
A. Data and preprocessing
This work was conducted on the publicly available Mul-
tiparameter Intelligent Monitoring in Intensive Care III
(MIMIC-3) database [13], which contains hospital admis-
sions from approximately 38600 individuals aged ≥ 15 years.
From MIMIC-3, we extracted a cohort of ICU patients ful-
filling 2 criteria: (1) at least one pain intensity score had been
collected, and (2) at least one dose of intravenous morphine
had been administered. A total of 6843 admissions fulfilled
these criteria. We chose to focus on morphine since this
was the most commonly prescribed opioid in the MIMIC-
3 database, followed by hydromorphone and oxycodone.
B. Feature extraction
For each patient, we extracted pain scores, analgesic
administration events and vital signs. Data were aggregated
into non-overlapping one-hour windows. When several data
points were available within a window, we replaced them
by either the mean (pain scores, vital signs) or the sum
(analgesic administrations). To account for missing data, we
utilized sample-and-hold interpolation as in [8]. In total, we
extracted 20 hourly features.
1) Pain scores: MIMIC-III contains scores in both numer-
ical and text format. The latter were converted to a numeric
score by using the scores referenced in the text (e.g. ”3-
Mild to Mod” becomes 3). All scores were reported in a 0
(no pain) to 10 (maximum pain) scale.
2) Morphine interventions: Morphine sulfate can be ad-
ministered intravenously either as a bolus or as a continuous
infusion with a steady rate for an extended period of time.
In this work, we considered intravenous boluses only, which
represented a majority of administrations for the studied
admissions (59.4%). These typically have an onset of 5-10
min and a half life of 3-4 hr. [14]. The dose, in addition to
time of administration, was recorded.
3) Non-morphine analgesic interventions: In order to
lower opioid consumption and to improve the quality of
analgesia, morphine is commmonly administered with ad-
juvant analgesics [14]. This includes nonopiod coanalgesics
such as nonsteroidal anti-inflammatory agents. Therefore, we
also extracted administrations of 16 analgesics in addition to
morphine.
4) Physiological signals: Morphine induces respiratory
depression [15] and impacts the cardiovascular system [16]
with potentially fatal consequences. Hence, we extracted two
relevant physiological signals: respiration rate (RR) and heart
rate (HR).
C. Continuous State-space and Discretized Action-space
The action space was discretized to 14 actions: 0, (0,1],
(1,2], ..., (9,10], (10,15], (15,20] and (20,∞) mg of mor-
phine intravenously. The state space, on the other hand,
was continuous and directly captured the patient’s self-
reported pain intensity and physiological state, as well as
non-morphine analgesic interventions.
Fig. 1. Example of a MIMIC-III patient’s time series of physiological data
and pain scores, together with the morphine administrations (discretized to
14 actions as described in Sec.III-C).
D. Reward function
At each time stamp t, the RL agent interacts with the
environment and observes the state st to choose whether to
deliver a morphine IV bolus (actions 1-13) or to withhold
morphine (action 0). The action at is chosen to maximize the
return, that is, the expected discounted future reward, defined
as Rt = ∑Tt ′=t γ
t ′−trt ′ , where T is the terminal timestep.
We defined a reward function rt(hr,rr, p) that incentivizes
pain reduction while seeking to maintain heart rate and
respiration rate within adequate physiological ranges. For
healthy adults at rest, heart rates between 60 and 100 beats
per minute and respiration rates between 12 and 20 breaths
per minute are considered acceptable.
rt(hr,rr, p) =CP ·rPt (pt)+CHR ·rHRt (hrt)+CRR ·rRRt (rrt) (1)
where CP =CHR =CRR = 13 and
rHRt (hrt) =
2
1+ e−(hrt−60)
− 2
1+ e−(hrt−100)
−1 (2)
rRRt (rrt) =
2
1+ e−(rrt−12)
− 2
1+ e−(rrt−20)
−1 (3)
rPt (pt) = 1−
2pt
10
(4)
This function assigns the maximum reward when pain is
absent and both heart rate and respiration rate are within the
acceptable range, while diminishing as they move away from
the ideal range.
E. Reinforcement learning model architecture
To learn the optimal treatment policies, we use Q-learning
[17], which works by learning an action-value Q(st ,at)
function that provides the expected return Rt of taking a
given action at each state, that is, Q(st ,at) = maxpi E[Rt ]
where the maximum is taken over all possible policies pi .
In Q-learning, the optimal action-value function is estimated
using the Bellman equation:
Q(st ,at) = Est+1∼T (st+1|st ,at )[r+ γ maxat+1
Q(st+1,at+1)|st ,at ] (5)
where T (st+1|st ,at) is the state transition distribution. Deep
Q-learning uses neural networks to approximate Q(st ,at) [6]
by sampling tuples < st ,at ,rt ,st+1 > and minimizing the
squared error loss between the output and target Q values,
where Qtarget = rt + γ maxat+1 Q(st+1,at+1;θ) and θ are
the weights used to parametrize the target network, using
stochastic gradient descent.
In this work, following [9], [10], we combined two
common extensions of the deep Q network (DQN) model:
double-deep Q networks (DDQN) [18] and dueling Q net-
works (dueling DQN) [19]. These address several shortcom-
ings of simple DQNs, such as their tendency to overestimate
Q values.
Our final network architecture was therefore a Dueling
Double-Deep Q Network (Dueling DDQN), It contained
two hidden layers with 64 nodes each, with Leaky-ReLu
activation functions and equally sized advantage and value
streams. As in [9], [10], we used prioritized experience
replay to sample transitions from the training set with
probability proportional to the previous error. The network
was implemented in TensorFlow.
IV. RESULTS
We separated 6843 hospital admissions into
70%/20%/10% training, validation and test sets respectively.
The action space was discretized to 14 actions as described
in Sec.III-C, based on visual inspection of the histogram of
morphine doses in MIMIC-III. The dueling DDQN model
was then trained using Adam optimization [20] with batch
size 32. After training, we obtained the optimal policy pi
for a given patient state s, such that pi(s) = argmaxa Q(s,a).
Unfortunately, quantitative evaluation of off-policy models
is challenging because it is difficult to assess the impact of
deploying the learned policy pi in patient outcomes. Hence,
we evaluated pi by qualitatively examining the choices of
treatments proposed by the model, and comparing these
with those made by physicians and our understanding of
accepted clinical guidelines.
Fig.2 depicts the comparison of actions taken by the physi-
cians with those recommended by the model, for every hour
in the test set. Action 0 refers to no morphine administered,
whereas actions 1-13 represent increasing morphine doses.
Physicians do not often prescribe morphine to patients (only
5.80% hourly timestamps contained morphine administra-
tion), but when they do, in 99% of instances the model
also recommended morphine administration. The agreement
between physician actions and model recommendations in
these instances is shown in Fig.3. The actions recommended
for the model for the 94.2% instances in which physicians
chose to withhold morphine are shown in Fig.2.
Fig. 2. (Left) Normalized histogram of physician and dueling DDQN
actions, where all actions that involved administration of morphine (actions
1-13) were grouped together. (Right) Histogram of dueling DDQN recom-
mended actions for those instances in which physicians chose to withhold
morphine (action 0).
Fig. 3. Histogram of physician against dueling DDQN actions for
those instances in which both physician and dueling DDQN recommended
administration of morphine (actions 1-13).
While physicians administer morphine sparsely, when they
do, a second morphine dose is administered in the next hour
in more than 40% of occasions, as shown in Fig.4. The
model, on the other hand, recommended more continuous
administration of morphine. This result is consistent with
previous studies comparing intermittent bolus versus contin-
uous infusion dosing of morphine, which have shown that
continuous dosing provides similar or even better pain relief
with no increase in acute adverse effects [21], [22].
V. CONCLUSION
This work builds on recent research using reinforcement
learning to automatically find optimal treatment policies to
improve patient outcome from training examples that do not
represent optimal behavior [8], [9], [10]. Here, we focus
on the problem of dosing opioid analgesics in the ICU.
While machine learning has been applied extensively to
the problem of pain recognition, to our knowledge this is
the first application of reinforcement learning for deducing
optimal intervention regimens to manage pain. We aimed to
demonstrate how deep reinforcement learning could be used
to suggest clinically interpretable treatment strategies for
pain using real-time patient data that are readily accessible.
This work has many limitations and should be taken as an
illustrative example. Morphine analgesia in the ICU is a
complex decision problem influenced by multiple factors.
Fig. 4. Histogram of morphine administration doses (top) and time between
administrations (bottom) for both physicians (left) and the dueling DDQN
algorithm (right).
However, our model simplified these clinical factors by
constraining the amount of variables considered and defining
a reward function that only aims to reduce pain while
keeping heart and respiration rates within a pre-defined
range. Therefore, possible directions for future work include
improving the state space by adding more data modalities,
extending the action space to include more dosing regimes
(e.g. co-analgesics), and increasing the sophistication of the
reward function to reflect the broader range of therapeutic
goals. Another limitation is that we used data from a single
center, which raises concerns about the generalizability of
our findings. Hence, future studies should include multiple
centers. Despite the limitations of this work, our learned
policy is consistent with research that shows that continuous
dosing is recommended over intermittent dosing.
Finally, deployment of this approach to opioid dosing
in clinical settings would first require extensive prospective
evaluation of the learned policies. The goal would not be to
replace physicians’ clinical judgments about treatment, but
to aid clinical decision making with insights about optimal
decisions and automatically guide therapy.
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